A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of Venglustat (GZ/SAR402671) in Parkinson's Disease Patients Carrying a Glucocerebrosidase (GBA) Gene Mutation Trial Phase 2 Terminated May 23, 2022
Risk Assessment in Patients With Symptomatic- and Asymptomatic Preexcitation Trial N/A Completed May 23, 2022
Effect of Probiotic on Constipation in Patients With Parkinson's Disease Trial N/A Unknown May 19, 2022
Unravelling the Alteration of Brain Structure and Function in Parkinson´s Disease With Ultra-high Field MRI Trial N/A Unknown May 17, 2022
A Systematic Investigation of Phonetic Complexity Effects on Articulatory Motor Performance in Progressive Dysarthria Trial N/A Completed May 16, 2022
Smart Home-based Technology to Promote Functional Mobility Among Individuals With Parkinson's Disease Trial N/A Unknown May 16, 2022
Effects of Complementary Therapies in People With Mild to Moderate Parkinson's Disease Trial N/A Completed May 16, 2022
Botulinum Toxin Type A for Foot Dystonia-associated Pain in Parkinson's Disease Trial Phase 2 Unknown May 16, 2022
A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's Disease Trial Phase 2 Completed May 10, 2022
A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment Trial Phase 2 Completed May 8, 2022